[Photo] CEO Lee Woo-seok Silent on 'Invossa Incident' Questions View original image


Lee Woo-seok, CEO of Kolon Life Science, who is suspected of being involved in the controversy surrounding the osteoarthritis gene therapy drug 'Invossa K Injection (Invossa)', is attending the pre-arrest suspect interrogation (warrant hearing) held on the 31st at the Seoul Central District Court in Seocho-gu, Seoul. / Reporter Moon Ho-nam munonam@



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing